Videos

While eating during treatment for head and neck cancer may be uncomfortable, Giselle Carnaby, PhD, MPH, CCC-SLP, ASHA fellow and professor at University of Central Florida College of Health and Public Affairs, emphasizes that it is vitally important.

Maria Cabanillas, MD, explains that for people who are newly diagnosed with thyroid cancer, it is imperative that they know all the details about their cancer before heading into surgery. 

After leading a study that patients with acute myeloid leukemia who receive induction chemotherapy are quite distressed, Tom LeBlanc, hematologic malignancy specialist at Duke Cancer Institute, decided more palliative care should be offered alongside treatment for the disease. 

Robert Andtbacka, MD, from University of Utah School of Medicine, discusses the management of side effects from T-VEC.

Mario E. Lacouture, MD, discusses the psychosocial impact of dermatologic adverse events from novel therapies in melanoma.

After being diagnosed with breast cancer, Susan Rafte and her sister started The Pink Ribbons Project is a Houston-based nonprofit that provides surrounding communities with access to fundamental breast health services via awareness programs, fundraising events and community collaboration.

Paula Raska, a research associate from the Cleveland Clinic, discusses a study of patient navigation.

Freya R. Schnabel, MD, discusses the importance of choosing individualized treatment options for patients with breast cancer.

Joseph Ravenell, MD, MS, discusses some of the challenges with screening black men for colon cancer.

Rajni Kannan discusses the role of nurses in skin cancer prevention education.

Samantha Ganey Aquino discusses results from a study of pain assessment.

Kathleen M. Madden discusses the management of adverse events (AEs) with BRAF and MEK inhibitors for the treatment of patients with melanoma.

Gwendolyn Quinn, PhD, discusses the importance of educating nurses and physicians about reproductive health.

Blake A. Morrison, PharmD, vice president, Medical and Scientific Affairs, Multiple Myeloma Research Foundation, discusses adverse events associated with new agents to treat patients with multiple myeloma.

Susan Hassmiller, PhD, RN, FAAN, senior advisor for nursing, Robert Wood Johnson Foundation, discusses what it means to

Smita Bhatia, MD, MPH, discusses the relationship between treatment for cancer and the development of other cancers.

Danielle Novetsky Friedman, a general pediatrician in the Pediatric Long-Term Follow-Up Program at Memorial Sloan Kettering Cancer Center (MSK), discusses a study investigating the mechanisms leading to abnormal glucose and insulin dynamics in survivors of childhood cancers.

Kevin Oeffinger, MD, Director of the Cancer Survivorship Center at Memorial Sloan Kettering Cancer Center, discusses the importance of cancer survivorship in the primary care setting.

Robin B. Brenner, RN, CRN, OCN, clinical research nurse, David M. Rubinstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, discusses adverse events associated with Onivyde (irinotecan liposome injection; MM-398) for pancreatic cancer.

Mary McCabe, director, Cancer Survivorship Initiative, Memorial Sloan Kettering Cancer Center, discusses the evolution of survivorship care.

Amy Callahan, RN, DNP, CRNP, AOCNS, nurse manager, Sidney Kimmel Cancer Center at Thomas Jefferson University, discusses barriers to safe handling of chemotoxic materials.

Phyllis McKiernan, MSN, APN, OCN, nurse practitioner, John Theurer Cancer Center at Hackensack University Medical Center, discusses blood and marrow transplantation and treating chronic myeloid leukemia (CML) with targeted therapies.

Sancy Leachman, MD, PhD, professor and chair, Department of Dermatology, director, Melanoma Research Program, Knight Cancer Institute, Oregon Health & Science University, discusses patients who are at high risk for developing melanoma.

Susan Hassmiller, PhD, RN, FAAN, senior advisor for nursing, Robert Wood Johnson Foundation, discusses the benefits of nurse residency programs.

G. Thomas Budd, MD, medical oncologist, Taussig Cancer Center at Cleveland Clinic, discusses genomic profiling for targeted therapies.

Miguel-Angel Perales, MD, deputy chief, Adult Bone Marrow Transplant Service, director, Adult Bone Marrow Transplantation Fellowship Program, Memorial Sloan Kettering Cancer Center, discusses graft versus host disease (GVHD) after a bone marrow transplant.

Debu Tripathy, MD, chair, Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses hormonal therapy for advanced and early-stage breast cancer.

Lisa Carey, MD, professor of medicine, University of North Carolina at Chapel Hill, discusses the need to minimize interventions for breast cancer treatment.